Department of Biomedical Sciences, Texas A&M University College of Dentistry, Dallas, TX 75246, USA; State Key Laboratory of Oral Diseases, Department of Traumatic and Plastic Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Department of Orthodontics, Texas A&M University College of Dentistry, Dallas, TX 75246, USA.
Bone. 2020 Feb;131:115151. doi: 10.1016/j.bone.2019.115151. Epub 2019 Nov 18.
Dentin matrix protein 1 (DMP1) is primarily expressed in osteocytes, although a low level of DMP1 is also detected in chondrocytes. Removing Dmp1 in mice or a mutation in humans leads to hypophosphatemic rickets (identical to X-linked hypophosphatemia). The deformed skeletons were currently thought to be a consequence of an inhibition of chondrogenesis (leading to an accumulation of hypertrophic chondrocytes and a failure in the replacement of cartilage by bone). To precisely study the mechanisms by which DMP1 and phosphorus control temporomandibular condyle formation, we first showed severe malformed condylar phenotypes in Dmp1-null mice (great expansions of deformed cartilage layers and subchondral bone), which worst as aging. Next, we excluded the direct role of DMP1 in condylar hypertrophic-chondrogenesis by conditionally deleting Dmp1 in hypertrophic chondrocytes using Col10a1-Cre and Dmp1 loxP mice (displaying no apparent phosphorous changes and condylar phenotype). To address the mechanism by which the onset of endochondral phenotypes takes place, we generated two sets of tracing lines in the Dmp1 KO background: AggrecanCreERT2-ROSA-tdTomato and Col 10a1-Cre-ROSA-tdTomato, respectively. Both tracing lines displayed an acceleration of chondrogenesis and cell trans-differentiation from chondrocytes into bone cells in the Dmp1 KO. Next, we showed that administrations of neutralizing fibroblast growth factor 23 (FGF23) antibodies in Dmp1-null mice restored hypophosphatemic condylar cartilage phenotypes. In further addressing the rescue mechanism, we generated compound mice containing Col10a1-Cre with ROSA-tdTomato and Dmp1 KO lines with and without a high Pi diet starting at day 10 for 39 days. We demonstrated that hypophosphatemia leads to an acceleration of chondrogenesis and trans-differentiation of chondrocytes to bone cells, which were largely restored under a high Pi diet. Finally, we identified the causative molecule (β-catenin). Together, this study demonstrates that the Dmp1-null caused hypophosphatemia, leading to acceleration (instead of inhibition) of chondrogenesis and bone trans-differentiation from chondrocytes but inhibition of bone cell maturation due to a sharp increase in β-catenin. These findings will aid in the future treatment of hypophosphatemic rickets with FGF23 neutralizing antibodies.
牙本质基质蛋白 1(DMP1)主要在骨细胞中表达,尽管在软骨细胞中也检测到低水平的 DMP1。在小鼠中去除 Dmp1 或人类中的突变会导致低磷性佝偻病(与 X 连锁低磷血症相同)。目前认为畸形骨骼是软骨生成抑制的结果(导致肥大软骨细胞的积累和软骨被骨取代的失败)。为了精确研究 DMP1 和磷控制颞下颌关节形成的机制,我们首先在 Dmp1 缺失小鼠中显示出严重的下颌骨畸形表型(畸形软骨层和软骨下骨的巨大扩张),随着年龄的增长而恶化。接下来,我们通过使用 Col10a1-Cre 和 Dmp1loxP 小鼠在肥大软骨细胞中条件性缺失 Dmp1,排除了 DMP1 在髁突肥大软骨细胞-软骨生成中的直接作用(未显示出明显的磷变化和髁突表型)。为了解释发生软骨内表型的机制,我们在 Dmp1 KO 背景下生成了两组示踪线:AggrecanCreERT2-ROSA-tdTomato 和 Col10a1-Cre-ROSA-tdTomato。两条示踪线均显示 Dmp1 KO 中软骨生成和软骨细胞向骨细胞的细胞转分化加速。接下来,我们表明在 Dmp1 缺失小鼠中给予中和成纤维细胞生长因子 23(FGF23)抗体可恢复低磷性髁突软骨表型。在进一步解决挽救机制时,我们生成了包含 Col10a1-Cre 与 ROSA-tdTomato 和 Dmp1 KO 线的复合小鼠,并用和不用高磷饮食从第 10 天开始,持续 39 天。我们证明低磷血症导致软骨生成和软骨细胞向骨细胞的转分化加速,而在高磷饮食下,这些加速大部分得到恢复。最后,我们确定了致病分子(β-catenin)。总之,这项研究表明,Dmp1 缺失导致低磷血症,导致软骨生成加速(而不是抑制)和软骨细胞向骨细胞的骨转分化,但由于β-catenin 的急剧增加,骨细胞成熟受到抑制。这些发现将有助于未来使用 FGF23 中和抗体治疗低磷性佝偻病。